Provincial report card
Saskatchewan
3 of 8 categories assessed · Evidence assessed to August 2025
Only 3 of 8 categories could be assessed from the research inventories, below the five-category minimum for a grade. The mean of the assessed categories (2.3) is shown for transparency only. Missing evidence is never scored as zero.
How Saskatchewan scored, category by category
1 · Strategy & pancreatic focus
2 / 4The Saskatchewan Cancer Agency Strategic Plan 2024–2028 is in operation, with population-based breast, cervical, and colorectal screening including mobile screening units and telehealth links; "pancreatic cancer is not highlighted as a distinct focus".
2 · Biomarker & genetic testing
2 / 4A funding approval framework for molecular biomarker testing is recorded "Established" (dated 7/1/2024) to guide funding approvals; no operating program is documented.
3 · Drug coverage & patient costs
Not assessableNot obtainable: Saskatchewan drug coverage and patient costs are not covered in the corpus.
4 · Clinical trials access
Not assessableNot obtainable: Saskatchewan clinical trials access is not covered in the corpus.
5 · Timely care — waits & surgical capacity
Not assessableNot obtainable: Saskatchewan wait times and pancreatic surgical capacity are not covered in the corpus.
6 · Travel & transport support
Not assessableNot obtainable: Saskatchewan travel and transport supports are not covered in the corpus.
7 · Workforce, navigation & support
Not assessableNot obtainable: Saskatchewan workforce and navigation are not covered in the corpus beyond telehealth links for supportive care.
8 · Research funding & representation
3 / 4Saskatchewan hosts one major pancreatic-flagged grant in the filtered CIHR register: the University of Saskatchewan's MUC-16 radioimmunoconjugate program (ovarian and pancreatic), $979,200.
Strongest areas
- Research funding & representation3 of 4
Grades rest on structured research inventories reviewed and verified by The Heather Cutler Foundation. They assess documented systems, not individual care. See all thirteen jurisdictions · Read the full report